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This paper describes a straightforward electrochemical method for rapid and robust urinary microRNA
(miRNA) quantification using disposable biosensors that can discriminate between urine from diabetic
kidney disease (DKD) patients and control subjects. Aberrant miRNA expression has been observed in
several major human disorders, and we have identified a urinary miRNA signature for DKD. MiRNAs
therefore have considerable promise as disease biomarkers, and techniques to quantify these transcripts
from clinical samples have significant clinical and commercial potential. Current RT-qPCR-based
methods require technical expertise, and more straightforward methods such as electrochemical
detection offer attractive alternatives. We describe a method to detect urinary miRNAs using diazo
sulfonamide-modified screen printed carbon electrode-based biosensors that is amenable to parallel
analysis. These sensors showed a linear response to buffered miR-21, with a 17 fM limit of detection, and
successfully discriminated between urine samples (n ¼ 6) from DKD patients and unaffected control
subjects (n ¼ 6) by differential miR-192 detection. Our technique for quantitative miRNA detection in
liquid biopsies has potential for development as a platform for non-invasive high-throughput screening
and/or to complement existing diagnostic procedures in disorders such as DKD.1. Introduction
MicroRNAs (miRNAs) are short single-stranded noncoding
RNAs that regulate the expression of most mammalian protein
coding genes. Aberrant miRNA expression proles have been
observed in major disorders including cancer, cardiovascular
disease, atherosclerosis, diabetes and chronic kidney disease
that requires treatment by dialysis or transplantation.1–4
While numerous previous studies have analysed the miRNA
content of blood and/or tissue samples,5,6 we have developed
RT-qPCR-based methods for precise quantication of miRNAs
in a variety of liquid biopsies. In hypothermic machine
perfusate, we showed that miR-21 may predict early renal
transplantation outcomes.7 In peritoneal dialysis effluent wefection & Immunity, School of Medicine,
Cardiff University, Heath Park, Cardiff
epair, Museum Place, Cardiff CF10 3BG,
ences and Engineering, Cardiff University,
tock, Bath BA3 4RT, UK
tion (ESI) available. See DOI:
is work.
39have identied neutrophil-derived miR-223 as a local biomarker
of bacterial peritonitis,8 and shown increased miR-21 in peri-
toneal brosis.9
Detection of urinary miRNAs as disease biomarkers is
particularly attractive, since this body uid is readily collected
without the need for invasive venepuncture or renal biopsy. We
have identied panels of urinary miRNAs that predict delayed
gra function following transplantation,10 and detect diabetic
kidney disease (DKD).11 Our DKD patient data also showed
signicantly decreased urinary miR-192 in those suffering from
DKD,11 supporting our previous ndings from renal biopsy
analyses.12
RT-qPCR is the current gold standard for miRNA quanti-
cation.13 We have used this technique in robust and accurate
quantication of urinary miRNAs, and shown that these tran-
scripts are stabilised by association with extracellular vesicles
and/or argonaute 2 protein.14 However, RT-qPCR requires
signicant technical expertise, a drawback to implementation
in routine testing at point-of-care.13,15
Methods using miRNA biosensors in blotting, uorescence,
and electrochemical procedures offer potentially attractive
alternatives to RT-qPCR.16–19 A wide variety of electrochemical
detection methods have been reported,17 including the use of
aptamer-based probes,20 DNAzymes and nanoparticles.21–23

























































































View Article Onlinetheir market potential is limited by requirements for compli-
cated sensor fabrication and end-user expertise.
We developed a straightforward proof-of-concept electro-
chemical miRNA detection biosensor using a glassy carbon
electrode (GCE) and DNA oligonucleotide with a sequence
complementary to the target miRNA.24 This technique was more
sensitive than RT-qPCR and discriminated between closely
related oligonucleotide sequences, but was unsuitable for cost-
effective clinical testing as the sensor required refabrication
between analyses.24 Consequently, we report here biosensors
prepared from inexpensive screen printed carbon electrodes
(SPCEs). Electrochemical analysis through the use of SPCEs can
be achieved using a portable potentiostat and consumables that
are an order of magnitude cheaper than an RT-qPCR instru-
ment, liquid handling system and reagents. SPCEs allow for
customisations through printed electrode arrays for detection
of multiple analytes or replicates, giving further benets in cost
reduction.
Fig. 1 summarises SPCE-based biosensor fabrication, with
SPCEs modied by deposition of diazotised naphthalene
sulfonic acid derivative 4-amino-3-hydroxy-1-napthalene
sulfonic acid (ANSA). The ANSA is then transformed into
a sulfonyl chloride (ANSCl) before a 50-amine-tagged miRNA-
specic DNA oligonucleotide is attached via a sulfonamide
linkage to complete the biosensor. The chemistry is easy to
perform, with ANSA and oligonucleotides readily available from
commercial suppliers. Biosensor readout is then carried out via
reductive and oxidative chronocoulometry (throughout short-
ened to coulometry), obtained by measuring negative andFig. 1 Fabrication ofmiRNA biosensors from screen printed carbon elect
diazo sulfonic acid deposition to form an ANSA surface (b), which is fu
terminated DNA strand complementary to the target miRNA, completing
electrochemically. For clarity, modification of only one of three working
© 2021 The Author(s). Published by the Royal Society of Chemistrypositive potential sweeps using a ferri/ferrocyanide electrolyte,
respectively, and readings are compared before and aer
miRNA-biosensor hybridization. The straightforward biosensor
preparation and measurement is an advantage over more
complex sensing platforms reported in the literature.17,20–23
Our novel SPCE-based biosensors are disposable, obviating
the previous drawbacks using GCEs, but maintain high
performance. Suitable for mass-production, they have potential
for cost-effective parallel analyses of liquid biopsy miRNA
biomarkers in the biochemistry laboratory and/or at point of-
care.2. Materials and methods
2.1 Materials and equipment
The following materials were obtained from the corresponding
suppliers: DNA oligonucleotides, K3[Fe(CN)6], K4[Fe(CN)6], strep-
tavidin peroxidase polymer (1 mg mL1), chloroform, diethyl
ether, ethanol, molecular biology grade water, from Merck (Wat-
ford, UK); tetramethylbenzidine (TMB) substrate solution, KCl,
PCl5, NaNO2 and RT-qPCR reagents from Thermo Fisher Scientic
(Gloucester, UK); RNA oligonucleotides from Integrated DNA
Technologies (Leuven, Belgium); 4-amino-3-hydroxy-1-napthalene
sulfonic acid (ANSA) from Fluorochem (Glossop, UK) and miR-
Neasy mini kit for miRNA extraction from Qiagen (Manchester,
UK). Screen printed carbon electrodes (SPCEs) fabricated with
proprietary ink formulations were supplied by Sun Chemical
(Bath, UK). The optimised ink formulation product codes for
SPCEs were: carbon (C2030519_P4), silver (C213016_D1) androdes (SPCEs). The bare SPCE surface (a) is modified by electrochemical
rther modified to a sulfonyl chloride (c) before addition of an amino
the biosensor (d). Hybridisation with the target miRNA (e) is detected
electrodes is shown.

























































































View Article Onlinedielectric (D2140114_D5). All DNA and RNA sequences used are
listed in Fig. S1 of the ESI.†
Electrochemical experiments were performed using a Palm-
Sens3 potentiostat (Alvatek, Tetbury, Gloucestershire, UK) with
MUX8 multiplexer and combined reference and auxiliary over 3
working surfaces of the SPCEs. Data were analysed through
PSTrace 5.4 supplied with the PalmSens3 potentiostat. Negative
potential sweep (reductive) coulometry was carried out by
applying a potential of 0.3 V for 0.1 s, 0.0 V for 2 s and nally
0.5 V for 2 s with measured intervals of 0.01 s; positive potential
sweep (oxidative) coulometry by applying a potential of 0.0 V for
0.1 s, 0.3 V for 2 s, and 0.0 V for 3 s with measured intervals of
0.01 s. Differential pulse voltammetry experiments were per-
formed between 0.3 V and 0.5 V at steps of 0.01 V, pulses of
0.05 V and 0.05 s at a scan rate of 0.05 V s1. All electrochemical
measurements were performed in 5 mM K4[Fe(CN)6)]/
K3[Fe(CN)6] in 0.1 M KCl. The resulting data were plotted, and
statistical analysis performed using GraphPad Prism® 9.2.2 Biosensor fabrication
Prior to sensor fabrication the ANSA was diazotised via reaction
with sodium nitrite in dilute hydrochloric acid. This helped
ensure irreversible covalent linkage of the coating to the SPCE
surface, which is more heterogeneous than the glassy carbon
electrode our group used previously.24 Before use, the SPCEs
were washed by submersion in 70% ethanol for 5 min and then
for 10 min in water.
Firstly, 4-amino-3-hydroxy-1-napthalene sulfonic acid
(48 mg, 11 mM) and sodium nitrite (17 mg, 14 mM) were dis-
solved in water (18 mL) and stirred to dissolution on ice. Once
cooled, 0.1 M hydrochloric acid (2 mL, 10 mM nal concen-
tration) was added dropwise over 5 min, the solution was stirred
for 30 min until development of a dark orange colour, and then
neutralised according to universal indicator paper with small
additions of sodium hydrogen carbonate. Without further
purication, 500 mL aliquots were stored at20 C until needed.
Following diazo-ANSA synthesis, the SPCE (see Fig. 2) was
rinsed with water for 5 min and then vortexed in water for
a further 2.5 min to remove surface debris. The electrode wasFig. 2 The design of the multi-surface SPCE used as the basis of our
miRNA biosensor. The process of screen printing is summarised: (a)
the silver/silver chloride tracers and reference are printed, (b) the
carbonworking and auxiliary surfaces are printed, and (c) the insulating
dielectric ink is printed to define each working electrode surface.
18834 | RSC Adv., 2021, 11, 18832–18839dried by shaking and connected to the potentiostat, 50 mL of
diazo-ANSA was added to each surface and electrochemically
deposited via 8 cycles of cyclic voltammetry between 0.5 V and
1.5 V at a scan rate of 20mV s1. Aer rinsing to remove residual
diazo-ANSA, the electrode was vortexed for a further 2.5 min to
remove any unbound diazo-ANSA, and then immersed in
a solution of PCl5 (250 mg, 40 mM) in diethyl ether (30 mL) for
1 h to convert the sulfonic acid moiety to a sulfonyl chloride.
The amino terminated DNA oligonucleotide with complemen-
tary sequence to the target miRNA (40 mL, 1 mM) dissolved in TM
buffer (50 mM Tris HCl, 20 mM MgCl2, pH 8.0) was then
denatured for 5 min at 90 C, added to each working surface of
the electrode and dried in a box oven at 80 C for 1 h.
Once dry, the biosensor (DNA-modied SPCE) surfaces were
rinsed with water for 5 min, vortexed in water for 2.5 min, and
then analysed electrochemically via coulometry to obtain an
initial baseline measurement corresponding to single-stranded
DNA on the biosensor surface. The cyclic voltammetry, reduc-
tive coulometry and oxidative coulometry measurements at
each stage are given in the ESI (Fig. S2–S5†).
2.3 Coulometry calibration plot for miR-21
The biosensors were rinsed to remove residual electrolyte, vor-
texed for 1 min to remove adsorbed electrolyte, and placed in
a well of a Teon block prior to addition of 800 mL of a TM-
buffered miR-21 dilution between 109 and 1014 M. The
Teon block was then placed on a rocking platform in
a hybridisation oven at 55 C for 1 h, aer which the biosensor
was removed and rinsed with TM buffer for 5 min, vortexed in
TM buffer for 2.5 min and analysed electrochemically via
coulometry. These nal measurements of the DNA–RNA hybrid
were compared to the initial measurement of the single-
stranded DNA baseline described above, and the difference in
the magnitude of the coulometric peak plotted against miR-21
concentration.
To obtain a miR-21 calibration plot, miR-21 biosensors were
hybridised in triplicate as described above (n ¼ 11). To account
for any batch-to-batch variability, readings were pooled over
different days from SPCEs generated in four separate print
cycles i.e. across multiple printed cards. This is displayed in the
error plotted as SEM. Triplicate readings for buffer alone (n¼ 6)
were used as baseline values to determine the limit of detection.
2.4 Urine sample processing and electrochemical miRNA
analysis
As described previously,11 urine samples were drawn from
Wales Kidney Research Tissue Bank, University Hospital of
Wales (Cardiff, UK) and ethical approval was granted by the
Wales Kidney Research Tissue Bank Governance Committee.
Prior to analysis, urine samples were pre-treated using
proteinase K and size exclusion spin ltration to remove
proteins and other macromolecular interferents. A 480 mL urine
aliquot was then mixed with 20 mL of proteinase K (20 mgmL1)
and CaCl2 (1 mg), and heated with shaking at 50 C for 10 min.
The urine was then pipetted onto a Millipore 10 kDa spin lter

























































































View Article Onlineltrate (100 mL) was diluted with TM buffer (900 mL) and the
electrode was immersed in the resulting solution at 55 C for
1 h. Electrochemical detection data for miR-192 were normal-
ised to those for miR-191 as we have detailed elsewhere.11
2.5 Urinary miRNA extraction and RT-qPCR analysis
Urinary miRNAs were extracted as we have described else-
where.14 Extracted miRNAs were taken up in 50 mL of RNase-free
water and stored at 80 C until use. RT-qPCR analysis was
carried out using a Thermo Fisher Scientic ViiA 7 System, with
normalisation of miR-192 to miR-191 data.14
2.6 Uric acid interference
Sensors were submerged in TM buffer solutions containing 0,
250, 500, 750 or 1000 mg L1 uric acid at 55 C for 1 h, and then
analysed electrochemically for evidence of interference. Then,
sensors were resubmerged in uric acid solutions at the same
concentration, but this time containing 1011 M miR-21, at
55 C for 1 h. Electrochemical analysis was used to compare
miR-21-dependent surface responses.
2.7 Analysis of DNA deposition
For analysis of DNA deposition at the electrode surface, biosen-
sors were fabricated (Fig. 1) using miR-21-specic DNA oligonu-
cleotides that were either unlabelled or biotinylated. Aer drying
at 80 C for 1 h, sensors were rinsed with water for 5 min and
vortexed for 2.5 min to remove unbound DNA. Incubation in
a blocking solution (5  SSC, 5% milk, 30 mL) was then carried
out for 30 min at room temperature before rinsing in wash
solution (5  SSC). Then, streptavidin-HRP (1 mL, 1 mg mL1)
dissolved in TM buffer (1 mL) was added as individual droplets
(30 mL) to sensors bearing labelled or unlabelled oligonucleotides
complementary to miR-21 and le for 30 min at room tempera-
ture, aer which the sensors were vortexed for 2.5 min in TM
buffer as a rst wash. Single sensors were then separated and
washed in water for 30 min with shaking, rinsed with water, and
placed in 2 mL microcentrifuge tubes with 250 mL of TMB
substrate solution for 12 min. Addition of stop solution (H2SO4,
0.18 M) resulted in a yellow colour change that was analysed
spectrophotometrically at 450 nm.
To investigate miRNA–DNA hybridisation at the electrode
surface, biosensors specic for miR-21 or negative control miR-
223 were fabricated. Sensors were then hybridised with a solu-
tion of biotinylated miR-21 RNA oligonucleotide (800 mL, 107 M)
before rinsing and vortexing with TM buffer. Blocking, strepta-
vidin addition (where appropriate), washing and analysis steps
were then repeated as detailed above.
2.8 Atomic force microscopy (AFM) imaging
AFM imaging was performed with tapping mode (TM)-AFM in
air at 293 K using a Nanoscope V instrument (Veeco, Plainview,
NY, USA) type multimode 8. PPP-NCHR PointProbe Plus silicon
SPM-sensor probes were used (Nanosensors, Neuchâtel, Swit-
zerland; nominal resonance frequency 330 kHz, force constant
42 N m1, length 125 mm) operating at a frequency of 321.5 kHz© 2021 The Author(s). Published by the Royal Society of Chemistryto image the surfaces through Scan Asyst-air mode, and data
were analysed with WSxM soware.3. Results
3.1 Sensor design
To date, the majority of SPCE-based miRNA-specic biosensors
have used single channel electrodes to detect singular miRNA
species.27–29 These include a dual working surface system,30 and
a method using DNA nanostructures on an array of 16 gold
electrodes.31
By contrast, Erdem et al. demonstrated multiplexed miRNA
detection using a system containing 16 active surfaces with
shared counter and reference electrodes,32 and in one case used
this set up to detect multiple miRNA species simultaneously.33
However these multiplex miRNA detection techniques required
a laborious magnetic bead separation procedure to isolate the
miRNA targets prior to analysis, and were tested on synthetic
miRNA solutions and not patient samples.
In contrast to the GCEs we used previously,24 we report here
our design of SPCEs incorporating 3 separate working surfaces
(Fig. 1 and 2) that shared a combined auxiliary and reference
electrode (Fig. 2). This design increased functionality and
throughput, facilitating triplicate readings of a single miRNA
species (Fig. 2). As an alternative, we are currently investigating
simultaneous detection of up to 3 different miRNA species.
SPCE degradation was observed during chlorination via PCl5
in acetone,24 impairing sensor function and thereby intro-
ducing a source of variability (data not shown). Following
extensive testing, chlorination using PCl5/diethyl ether for up to
3 h was possible without visible SPCE damage or decreased
biosensor response (see below).3.2 Sensor sensitivity
Coulometry was chosen as the electrochemical analysis method
as it has been used successfully in our previous work and that of
others,24–26 can be run in less than 5 seconds and is easily
quantied by the magnitude of the scan peak which exhibits
minimal background noise. Electrochemical impedance spec-
troscopy was explored as an alternative due to its ability to
provide insight into the electrode-solution interface. However,
difficulties in tting a meaningful equivalent circuit model to
the data from our SPCEs, and the short coulometric scan times
and straightforward data processing led to the latter analysis
being selected as the preferred method to take forward for our
disposable SPCEs.
Custom SPCEs were used for miR-21 biosensor fabrication as
described above, and sensitivity was quantied using buffered
miR-21 serial dilutions as shown in Fig. 3 TOP, Fig. S6 and S7
(ESI†). A linear response was observed between 108 M and
1014 M (Pearson regression R2 ¼ 0.98) that concurred with our
previous GCE data.24 This value was obtained from pooling of
data points taken over multiple sensor print cycles, thus
including the effect of batch-to-batch variability in the error
bars shown. An SPCE limit of detection of 17 fM compared
favourably with our GCE value of 20 fM (Fig. 3 bottom, ESIRSC Adv., 2021, 11, 18832–18839 | 18835
Fig. 3 (Top) Example coulometric response following hybridisation of
SPCE-biosensor with decreasing concentrations of miR-21. (Bottom)
Reductive coulometric SPCE miR-21 biosensor response following
hybridisation with varying concentrations of miR-21 over 4 separate
experiments in [Fe(CN)6]
3/4 in 0.1 M KCl. Data are expressed asmean

























































































View Article OnlineFig. S7†),24 and is on a par with other disposable miRNA elec-
trochemical sensors in the literature.34,35 This limit of detection
was calculated from 6 readings using a blank buffer solution
containing no miRNA.
The calibration plot (Fig. 3) was produced from sensors
taken over 4 separately printed cards of 9 electrodes each. Minor
variations between SPCE replicates when plotting DQ against
[miR-21], shown by the standard error of the mean (SEM) error
bars, reect card-to-card differences. Differential pulse voltam-
metry was also performed (ESI, Fig. S8 and S9†) to conrm,
although this method showed greater variability so was not
taken forward.Fig. 4 Reductive coulometry (Echem) and RT-qPCR (PCR) analysis of
urinary miR-192 relative expression in DKD patients and control
subjects. Data were normalised to miR-191 and are expressed as
means  SEM (n ¼ 6).* p < 0.05.3.3 Urinary analysis
To the best of our knowledge, the typical absolute molar
concentration range of miRNA species in urine have not been
established denitively. Our previous report showed evidence
for detection of urinary miR-21 from healthy controls in the pM
concentration range,24 a range supported by luminescence-
based detection.36 The 17 fM detection limit we report here is
orders of magnitude more sensitive, and is therefore suitable
for reliable qualitative urinary miRNA analysis.
To test the utility of our SPCE biosensors to detect DKD
biomarkers, we analysed miR-192 in patient and control urine18836 | RSC Adv., 2021, 11, 18832–18839samples. We have shown previously that miR-192 abundance
decreases in biopsy samples from DKD patients.12 Our electro-
chemical data were compared to the results of parallel RT-qPCR
analysis, with relative expression data for miR-192 normalised
to those for miR-191 as we have described elsewhere.11 For both
electrochemical and RT-qPCR detection, signicant differences
in miR-192 detection were observed between unaffected indi-
viduals and DKD patients (Fig. 4). Using our sensor, miR-192
expression with respect to miR-191 fell from a 1.54 fold
change in the control cohort to 0.66 fold change in the patients.
This was in good agreement with RT-qPCR analysis of the same
samples which showed a decrease from 1.54 fold in the controls
to 0.46 in the patients. Similarly, oxidative coulometry (ESI,
Fig. S10†) showed the same change in effect, albeit slightly more
pronounced, dropping from a 2.15 fold change in controls to
0.54 in the patients.
We then prepared a serial dilution series from one control
urine sample and carried out coulometric analysis for miR-21 to
control for interference from contamination with macromole-
cules such as proteins that might exhibit non-specic high
affinity binding to the electrode surface. The linear relationship
observed suggested that there was no signicant contamination
(ESI, Fig. S11†).
The effect of interference by proteins and small molecules
has been referred to in other literature.36,37 To avoid these issues
of non-specicity, a full extraction procedure is oen used to
isolate the miRNA prior to analysis,37–39 whereas “pre-treatment
free” approaches oen use synthetic miRNA spiked-in to the
urinary matrix which is then analysed.36 Our simple proteinase
K treatment avoids laborious full extraction procedures such as
those we describe herein prior to RT-qPCR analysis, but facili-
tates direct urinary miRNA measurement in a simple, poten-
tially scalable protocol.
In our previous work, we investigated the direct analysis of

























































































View Article Onlinedetermined that salt and urea do not interfere, however protein
in the form of bovine serum albumin (BSA) was problematic.
We therefore implemented the aforementioned urine pre-
treatment of proteinase K incubation and ltration. In this
research we have also investigated the impact of uric acid as
another potential interferent. Uric acid is normally excreted in
urine at a level of 250–750 mg over a 24 h period. We found that
uric acid at or above the normal range resulted in no interfer-
ence. No change in response was observed when biosensors
were submersed in uric acid solutions in the absence of miR-21.
None of the uric acid solutions prevented or interfered with the
response of the same sensor to 1011 M miR-21 (ESI, Fig. S12
and S13†).3.4 Surface chemistry analysis
Biosensor-miRNA interaction was then characterised further.
Streptavidin/biotin chemistry was used to provide further
evidence for SPCE–DNA oligonucleotide attachment and oligo-
nucleotide–miRNA binding (Table 1).
Firstly, a miR-21 biosensor was prepared using non-
biotinylated or biotinylated DNA oligonucleotides complemen-
tary to miR-21 (Table 1a). Streptavidin-HRP conjugate was
applied to one non-biotinylated biosensor and one biotinylated
biosensor. A further non-biotinylated biosensor was not exposed
to conjugate. Following blocking, colour development by
immersion in TMB substrate solution, and sulfuric acid stop
solution, a >12 fold increase in signal was observed using the
biotinylated oligonucleotide-based biosensor (Table 1a), the
predicted outcome if oligonucleotide attachment was successful.
The specicity of miR-21 detection was then investigated by
comparing hybridisation of biotinylated miR-21 with non-
biotinylated miR-21 and miR-223 biosensors (Table 1b).
Following exposure to biotinylated miR-21 RNA, streptavidin
treatment and spectrophotometric analysis, a >11-fold signal
increase was observed for the miR-21 biosensor compared to its
miR-223 counterpart (Table 1b). These data demonstrated that
the biosensor DNA oligonucleotide-miR-21 interaction was
specic.3.5 Surface tapping mode-atomic force microscopy (TM-
AFM) imaging
TM-AFM was then used to visualise the SPCE surface. As shown
in Fig. 5, the following key steps in biosensor preparation wereTable 1 A450 readings from TMB substrate and stop solution  strept
biosensors and (b) non-biotinylated miR-21 or miR-223 biosensors hybr
Spectrophotometric analysis at 450 nm (A450)
(a) Non-biotinylated or biotinylated (bio) miR-21 biosensors
Comp-miR-21
 S-HRP Comp-miR-21 + S-HRP 30-Bio-comp-miR-21 + S-HRP
0.000a 0.010  0.002 0.123  0.014
a Baseline response  streptavidin has been subtracted from the data, va
provided elsewhere (ESI, Fig. S1).
© 2021 The Author(s). Published by the Royal Society of Chemistryvisualised: (a) the initial untreated SPCE surface, (b) the SPCE
surface following ANSA deposition and (c) the SPCE sensor
surface following DNA oligonucleotide attachment. Biosensors
were then imaged aer DNA/RNA hybridisation using (d) buff-
ered synthetic miRNA, (e) untreated urine and (f) urine
following proteinase K treatment and then ltration.
In Fig. 5a, clear triangular layered steps and terraces are
observed in the topography of the carbon ink at the unmodied
SPCE surface. The surface steps are sharp, with a typical length
of 1.75 mm. Following electrodeposition of ANSA onto the SPCE
surface these triangular layers can still be seen, but appear
smoother and more rounded (Fig. 5b). Following DNA attach-
ment to the SPCE surface via sulfonamide linkage (Fig. 5c),
completing the biosensor structure, the image shows surface
coverage by numerous small round artefacts approximately
40 nm in diameter, conceivably single-stranded DNA oligonu-
cleotide clusters (Fig. 5c). A similar image is obtained following
hybridisation with the target miRNA (Fig. 5d), with prevalent
surface coverage by slightly larger round bodies of approxi-
mately 90 nm diameter.
The nal two images relate to the biosensor surface
following immersion in urine, one sample of which was
unprocessed (Fig. 5e) and one sample which had been pro-
cessed with proteinase K and membrane ltration (Fig. 5f). In
Fig. 5e the round bodies described above that covered the
biosensor surface were generally localised to the corners and
edges of the triangular layers, and were larger than bodies
observed in Fig. 5d, measuring approximately 120 nm in
diameter. By contrast, Fig. 5f shows rounded bodies of
approximately 80 nm located closer to the centre of the trian-
gular terraces, closely resembling those seen in Fig. 5d.
These observations are consistent with our previous work,
where unprocessed urine interfered with the electrochemical
response of our glassy carbon biosensor to miRNA hybrid-
isation.24 These ndings provide strong evidence that the use
of proteinase K and spin ltration removed contaminating
lipids and macromolecules such as proteins and thereby pre-
vented fouling of the biosensor surface. This ensured unim-
peded biosensor miRNA hybridisation and accurate
electrochemical output. Selected wider eld images captured
throughout the fabrication process are provided in the ESI
(Fig. S14†).avidin-HRP (S-HRP) for (a) non-biotinylated and biotinylated miR-21
idised with 107 M 50-bio-miR-21
(b) Non-biotinylated miR-21/miR-223 biosensors + 50-bio-miR-21
Comp-miR-21
 S-HRP Comp-miR-223 + S-HRP Comp-miR-21 + S-HRP
0.000a 0.008  0.003 0.091  0.006
lues are expressed as mean  SD (n ¼ 3). Oligonucleotides' details are
RSC Adv., 2021, 11, 18832–18839 | 18837
Fig. 5 TM-AFM images of the SPCE when (a) unmodified, (b) following ANSA deposition, (c) following DNA attachment, (d) after hybridisation


























































































View Article Online4. Conclusions
In summary, we have demonstrated the utility of disposable
SPCE-based biosensors for robust and highly sensitive miR-21
quantication in buffered solution. These biosensors were
also able to replicate RT-qPCR data that discriminated between
urine samples from DKD patients and unaffected control indi-
viduals on the basis of miR-192 expression relative to miR-191.
We have therefore demonstrated that our disposable SPCE-
based biosensors have potential for use in rapid urinary
miRNA biomarker quantication. We have identied miRNA
expression proles associated with several renal and renal-
related pathologies.7–12 The low cost and commercial avail-
ability of all materials used in our disposable sensor, along with
its rapid production and short analysis time, make it highly
advantageous to a nancially pressed health service. With this
in mind, we will now look to adapt our technologies for use in
clinical testing. Future work will also investigate the simulta-
neous detection of multiple miRNAs on one sensor, as well as
the triplicate reading usage presented here. Further enhance-
ments of the sensor are being developed while investigating
shelf life, storage conditions and use in different biological
uids including peritoneal dialysis effluent.18838 | RSC Adv., 2021, 11, 18832–18839Conflicts of interest
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